[ACRV] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[ACRV] Acrivon Therapeutics, Inc. Common Stock
Announcement Date
09-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -40.52%
YoY- -53.83%
Quarter Report
ACRV's Result
ACRV's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 1,884 0 0 0 0 0 0 -
PBT -19,252 -14,466 -13,914 -12,756 -8,929 -9,198 -5,820 121.52%
Tax 1,770 -133 7 -1,637 -1,016 -377 -105 -
NP -19,252 -14,466 -13,914 -11,119 -7,913 -8,821 -5,715 124.22%
Tax Rate - - - - - - - -
Total Cost 21,136 14,466 13,914 11,119 7,913 8,821 5,715 138.58%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -1,021.87 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -0.86 -0.66 -0.63 -0.51 -0.38 -0.47 -0.44 56.13%
EPS Diluted -0.86 -0.66 -0.63 -0.51 -0.38 -0.47 -0.44 56.13%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.